Invention Application
- Patent Title: CRYSTALLINE BROMODOMAIN INHIBITORS
- Patent Title (中): 结晶胆红素抑制剂
-
Application No.: US15355876Application Date: 2016-11-18
-
Publication No.: US20170066765A1Publication Date: 2017-03-09
- Inventor: Yuchuan Gong
- Applicant: AbbVie Inc.
- Main IPC: C07D471/04
- IPC: C07D471/04
Abstract:
N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
Information query
